A R T I C L E S
Chenevier et al.
spectroscopy (TOF MS) analysis gave for RGDH and RGEH 1139.4
(MALDI) and 1156 (ESI), for calculated mass of protonated species
1139.3 and 1154.4, respectively.
Lipophilic R-oxoaldehyde (LA) was prepared as described previ-
ously.19 Water soluble R-oxoaldehyde (WA) was kindly provided by
Nathalie Ollivier: peptide SKYVL-NH2 was prepared by automatic
solid-phase peptide synthesis and oxidized by periodate oxidation.20
Lipid-ligands LRGD and LRGE were prepared and used as described
previously.14,18
Figure 1. Grafting of ligands (hand motifs) onto onion vectors using the
R-oxohydrazone ligation; transmission electron microscopy image from ref
16.
The composition of common buffers were Tris 10 mM/EDTA 1 mM
at pH 7.4 and acetic acid 100 mM at pH 4.6. Other buffers were
hydrochloric (HCl 200 mM + KCl 200 mM, pH 1 to 2), citrate-
phosphate (citric acid 50 mM + Na2HPO4 100 mM, pH 2.6 to 7), acetic
(acetic acid 100 mM + NaOH, pH 3.6 to 5), carbonate (K2CO3 50
mM + HCl, pH 8 to 9.6), and phosphate (Na2HPO4 50 mM + Na3PO4
50 mM, pH 10 to 12) buffers.
2.2. Micelles, Liposomes, and Onion Vectors. For micelle prepara-
tions, LA dissolved in ethanol at 60 °C was mixed with surfactant C12E7
and finally dispersed in excess buffer. Final concentrations were 25 to
100 µM in LA, 0.25 to 1 wt % (5 to 21 mM) in C12E7 and less than 2%
ethanol.
For liposomes and onion vectors, lipids were mixed in ethanol at
45 °C, and the ethanol was evaporated under vacuum, prior to the
addition of pure water to achieve the final weight compositions: PC/
Sim/water 45:20:35 for control and LA/PC/Sim/water 6.5:38.5:20:35
for LA onion vectors. Samples were incubated over half a day, before
the lamellar phase was sheared between the cone tube walls and a
matching cone pestle. The onion vector suspension was produced by
adding a 10 time excess of pure water. For liposomes, the previous
stock suspension was diluted 10 times in buffer and sonicated at high
power for 10 min (10 W in 1 mL sample). Metal particles from the
sonication probe were removed by a short centrifugation.
2.3. Determination of Reaction Rate Constants by Fluorometry.
Rates of reaction with MBTH were measured by recording the
fluorescence of the sample, after adding MBTH to a solution or colloidal
suspension containing the aldehyde reagent A (WA or LA) to produce
product P:
excess water. A suspension of multilamellar vesicles with
concentric membranes up to the core is obtained.9 They have
proved efficient as vectors for the transport of active compounds
in vivo as well as in vitro,10,11 especially for vaccine delivery.12,13
We have recently described their first applications as neutral
targeted vectors. First, we used RGD ligands attached to a lipid
moiety to ensure their association to the onion vectors.14 The
strategy was successful; however, the synthesis of the lipid-
ligands proved to be delicate. Therefore, we turned to a ligation
strategy, using reactive synthetic lipids in the onion vectors to
graft mannose mimetic ligands in situ15 (Figure 1). In the present
study, we intend to fully understand the ligation process, so
that the grafting onto onion vectors can be easily adapted to
any type of ligands.
Here, we report a complete characterization of the reaction
of R-oxohydrazone bond formation, in aqueous solution as well
as in self-organized media. As R-oxohydrazone bonds were
difficult to detect in complex media, we first studied the
mechanism, kinetics, and thermodynamics of the reaction using
closely related model reagents. We then used optimal conditions
for the grafting of targeting ligands, RGD peptides, onto onion
vectors, and tested the biological efficiency of the grafted vectors
on target cells in vitro.
2. Experimental Section
2.1. Reagents and Chemicals. The buffer compounds, 3-methyl-
2-benzothiazolinone hydrazone (MBTH) hydrochloride, dioleoyltri-
methylaminomethane (DOTAP), and polyoxyethylene 7 lauryl ether
(C12E7) were provided by Sigma, soybean phosphatidylcholine S100
(PC) was provided by Lipoid (France), and polyoxyethylene 8
stearoylester or Simulsol2599 (Sim) was provided by SEPPIC (France).
Hydrazinoacetyl peptides RGDH and RGEH were synthesized by
solid-phase peptide synthesis, with Fmoc/tert-butyl standard procedures
and hydrazine coupling methods developed by Bonnet et al.17 Briefly,
the YGRGDSP and YGRGESP sequences were synthesized automati-
cally.18 A glutaric moiety, 4,7,10-trioxa-1,13-tridecanediamine, and
N,N′,N′-tri(tert-butyloxycarbonyl)hydrazinoacetic acid were coupled
manually. The products were then cleaved and purified by RP-HPLC
with 61% (RGDH) and 56% (RGEH) overall yield. The mass
A + MBTH
9
k8 P + H2O
(1)
where k is the global reaction rate constant. The rate constant of the
reverse reaction was supposed to be negligible compared to k, a
hypothesis justified by the high stability of P. Fluorescence intensity
was measured in a thermostated 5 mm square quartz cuvette, using a
Fluoromax (Spex, USA) fluorometer. The fluorescence intensity
(excitation 366 nm, emission 495 nm) was linear in the concentration
of P up to 60 µM and 100 µM for the products of reaction of MBTH
with WA and LA, respectively (data no shown). Fluorescence intensity
time series were then fitted to the second-order reaction rate equation:
1 - e-t/τ
IF ) IF0 + IFmax
(2)
1 - (a/n)e-t/τ
(9) Gulik-Krzywicki, T.; Dedieu, J. C.; Roux, D.; Degert, C.; Laversanne, R.
Langmuir 1996, 12, 4668-4671.
where τ ) k-1(n - a)-1, IF, IF0, and IFmax are the recorded
instantaneous, initial, and final fluorescence intensities, respectively,
and a and n, the initial global concentrations of A and MBTH (τ, IF0,
and IFmax were the adjustable parameters). k was determined from
several values of τ measured with different values of n and a.
Concentrations ranged typically from 200 µM to 2 mM for MBTH and
between 5 and 100 µM for R-oxoadehydes.
(10) Freund, O.; Ame´de´e, J.; Roux, D.; Laversanne, R. Life Sci. 2000, 67, 411-
419.
(11) Mignet, N.; Brun, A.; Degert, C.; Delord, B.; He´le`ne, C.; Laversanne, R.;
Franc¸ois, J.-C. Nucleic Acids Res. 2000, 28, 3134-3142.
(12) Gaubert, S. World Patent WO99/16468, 1998.
(13) Gaubert, S. World Patent WO01/19335A2, 2001.
(14) Chenevier, P.; Delord, B.; Ame´de´e, J.; Bareille, R.; Ichas, F.; Roux, D.
Biochim. Biophys. Acta 2002, 1593, 17-27.
(15) Chenevier, P.; Grandjean, C.; Loing, E.; Malingue, F.; Angyalosi, G.; Gras-
Masse, H.; Roux, D.; Melnyk, O.; Bourel-Bonnet, L. Chem. Commun. 2002,
20, 2446-2447.
(16) Roux, D.; Chenevier, P.; Pott, T.; Navailles, L.; Regev, O.; Mondain
Monval, O. Curr. Med. Chem., to be published.
Concentrations of nonprotonated hydrazines vary with pH so that
global rate constants cannot be directly compared at different pHs. For
varying pHs, the global rate constant k was corrected into kcorr as
(17) Bonnet, D.; Grandjean, C.; Rousselot-Pailley, P.; Joly, P.; Bourel-Bonnet,
L.; Santraine, V.; Gras-Masse, H.; Melnyk, O. J. Org. Chem. 2003, 68,
7033-7040.
(19) Bourel-Bonnet, L.; Gras-Masse, H.; Melnyk, O. Tetrahedron Lett. 2001,
42, 6851-6853.
(20) Georgheran, K. F.; Stroh, J. G. Bioconjugate Chem. 1992, 3, 138-146.
(18) See Supporting Information for details.
9
16262 J. AM. CHEM. SOC. VOL. 125, NO. 52, 2003